glutamate receptor, ionotropic, AMPA1 (alpha 1) |
DILTIAZEM |
Glutamate, AMPA |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA2 |
DILTIAZEM |
Glutamate, AMPA |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
DILTIAZEM |
Glutamate, AMPA |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor subunit 4c |
DILTIAZEM |
Glutamate, AMPA |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
TOLPERISONE |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
TOLPERISONE |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
TOLPERISONE |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, pi |
TOLPERISONE |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
AT hook, DNA binding motif, containing 1 (DBSS) |
TOLPERISONE |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, theta |
TOLPERISONE |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
TOLPERISONE |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
TOLPERISONE |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
SALSALATE |
Calcium Channel Type L, Phenylalkylamine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
SALSALATE |
Calcium Channel Type L, Phenylalkylamine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
SALSALATE |
Calcium Channel Type L, Phenylalkylamine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
SALSALATE |
Calcium Channel Type L, Phenylalkylamine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
SALSALATE |
Calcium Channel Type L, Phenylalkylamine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
SALSALATE |
Calcium Channel Type L, Phenylalkylamine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
SALSALATE |
Calcium Channel Type L, Phenylalkylamine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
SALSALATE |
Calcium Channel Type L, Phenylalkylamine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
SALSALATE |
Calcium Channel Type L, Phenylalkylamine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
SALSALATE |
Calcium Channel Type L, Phenylalkylamine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
SALSALATE |
Calcium Channel Type L, Phenylalkylamine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
SALSALATE |
Calcium Channel Type L, Phenylalkylamine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
SALSALATE |
Calcium Channel Type L, Phenylalkylamine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
SALSALATE |
Calcium Channel Type L, Phenylalkylamine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
SALSALATE |
Calcium Channel Type L, Phenylalkylamine |
-14% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4A, cAMP specific |
NATEGLINIDE |
Phosphodiesterase PDE4 |
-14% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4C, cAMP-specific |
NATEGLINIDE |
Phosphodiesterase PDE4 |
-14% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4D |
NATEGLINIDE |
Phosphodiesterase PDE4 |
-14% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4B, cAMP specific |
NATEGLINIDE |
Phosphodiesterase PDE4 |
-14% |
NoneNone |
NoneNone |
View
|
adenosine A1 receptor |
SALICYLIC ACID |
Adenosine A1 |
-14% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
NATEGLINIDE |
Protein Tyrosine Kinase, HER2 Receptor |
-14% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
NATEGLINIDE |
Protein Tyrosine Kinase, HER2 Receptor |
-14% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 5A, cGMP-specific |
PHENACETIN |
Phosphodiesterase PDE5 |
-14% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 5A, cGMP-specific |
PHENACETIN |
Phosphodiesterase PDE5 |
-14% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 5 |
NATEGLINIDE |
Muscarinic M5 |
-14% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 9 |
NATEGLINIDE |
Nicotinic Acetylcholine, Central |
-14% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 10 |
NATEGLINIDE |
Nicotinic Acetylcholine, Central |
-14% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, epsilon polypeptide |
NATEGLINIDE |
Nicotinic Acetylcholine, Central |
-14% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 4 |
NATEGLINIDE |
Nicotinic Acetylcholine, Central |
-14% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 5 |
NATEGLINIDE |
Nicotinic Acetylcholine, Central |
-14% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) |
NATEGLINIDE |
Nicotinic Acetylcholine, Central |
-14% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 4 polypeptide |
NIMESULIDE |
ATPase, Na+/K+ |
-14% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
NIMESULIDE |
ATPase, Na+/K+ |
-14% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
NIMESULIDE |
ATPase, Na+/K+ |
-14% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
NIMESULIDE |
ATPase, Na+/K+ |
-14% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
NIMESULIDE |
ATPase, Na+/K+ |
-14% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 3 polypeptide |
NIMESULIDE |
ATPase, Na+/K+ |
-14% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 2 polypeptide |
NIMESULIDE |
ATPase, Na+/K+ |
-14% |
NoneNone |
NoneNone |
View
|
ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
NIMESULIDE |
ATPase, Na+/K+ |
-14% |
NoneNone |
NoneNone |
View
|
dopamine receptor 2 |
NATEGLINIDE |
Dopamine D2L |
-14% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
NATEGLINIDE |
Serotonin Transporter |
-14% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 1a |
NIACIN |
Adrenergic alpha1A |
-14% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
SPECTINOMYCIN |
Chemokine CCR5 |
-14% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 3 |
MODAFINIL |
Muscarinic M3 |
-14% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
NIMESULIDE |
Chemokine CCR5 |
-14% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y2 |
SPECTINOMYCIN |
Neuropeptide Y2 |
-14% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y2 |
SPECTINOMYCIN |
Neuropeptide Y2 |
-14% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y2 |
SPARFLOXACIN |
Neuropeptide Y2 |
-14% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y2 |
SPARFLOXACIN |
Neuropeptide Y2 |
-14% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
SALSALATE |
Glutamate, NMDA, Phencyclidine |
-14% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
SALSALATE |
Glutamate, NMDA, Phencyclidine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
GADOPENTETATE DIMEGLUMINE |
Calcium Channel Type L, Benzothiazepine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
GADOPENTETATE DIMEGLUMINE |
Calcium Channel Type L, Benzothiazepine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
GADOPENTETATE DIMEGLUMINE |
Calcium Channel Type L, Benzothiazepine |
-14% |
NoneNone |
NoneNone |
View
|
protein kinase C, delta |
ZIRCONIUM(IV) CHLORIDE |
Phorbol Ester |
-14% |
NoneNone |
NoneNone |
View
|
protein kinase C, mu |
ZIRCONIUM(IV) CHLORIDE |
Phorbol Ester |
-14% |
NoneNone |
NoneNone |
View
|
protein kinase C, theta |
ZIRCONIUM(IV) CHLORIDE |
Phorbol Ester |
-14% |
NoneNone |
NoneNone |
View
|
protein kinase C, iota |
ZIRCONIUM(IV) CHLORIDE |
Phorbol Ester |
-14% |
NoneNone |
NoneNone |
View
|
protein kinase C, epsilon |
ZIRCONIUM(IV) CHLORIDE |
Phorbol Ester |
-14% |
NoneNone |
NoneNone |
View
|
protein kinase C, zeta |
ZIRCONIUM(IV) CHLORIDE |
Phorbol Ester |
-14% |
NoneNone |
NoneNone |
View
|
protein kinase C, gamma |
ZIRCONIUM(IV) CHLORIDE |
Phorbol Ester |
-14% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
ZIRCONIUM(IV) CHLORIDE |
Phorbol Ester |
-14% |
NoneNone |
NoneNone |
View
|
protein kinase C, delta |
ZIRCONIUM(IV) CHLORIDE |
Phorbol Ester |
-14% |
NoneNone |
NoneNone |
View
|
protein kinase D1 |
ZIRCONIUM(IV) CHLORIDE |
Phorbol Ester |
-14% |
NoneNone |
NoneNone |
View
|
protein kinase C, theta |
ZIRCONIUM(IV) CHLORIDE |
Phorbol Ester |
-14% |
NoneNone |
NoneNone |
View
|
protein kinase C, epsilon |
ZIRCONIUM(IV) CHLORIDE |
Phorbol Ester |
-14% |
NoneNone |
NoneNone |
View
|
protein kinase C, gamma |
ZIRCONIUM(IV) CHLORIDE |
Phorbol Ester |
-14% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
VERAPAMIL |
GABAA, Agonist Site |
-14% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
VERAPAMIL |
GABAA, Agonist Site |
-14% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
VERAPAMIL |
GABAA, Agonist Site |
-14% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
VERAPAMIL |
GABAA, Agonist Site |
-14% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
VERAPAMIL |
GABAA, Agonist Site |
-14% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
VERAPAMIL |
GABAA, Agonist Site |
-14% |
NoneNone |
NoneNone |
View
|
cannabinoid receptor 1 (brain) |
CISPLATIN |
Cannabinoid CB1 |
-14% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
CISPLATIN |
Adrenergic, Norepinephrine Transporter |
-14% |
NoneNone |
NoneNone |
View
|
estrogen receptor 1 |
CETRAXATE |
Estrogen ERalpha |
-14% |
NoneNone |
NoneNone |
View
|
estrogen receptor 1 |
CETRAXATE |
Estrogen ERalpha |
-14% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 1b |
EPERISONE |
Tumor Necrosis Factor (TNF), Non-Selective |
-14% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 1a |
EPERISONE |
Tumor Necrosis Factor (TNF), Non-Selective |
-14% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 4 |
EPERISONE |
Tumor Necrosis Factor (TNF), Non-Selective |
-14% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
EPERISONE |
Tumor Necrosis Factor (TNF), Non-Selective |
-14% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 8 |
EPERISONE |
Tumor Necrosis Factor (TNF), Non-Selective |
-14% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 5 (DBSS) |
EPERISONE |
Tumor Necrosis Factor (TNF), Non-Selective |
-14% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
FLEROXACIN |
Purinergic P2X |
-14% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 7 |
FLEROXACIN |
Purinergic P2X |
-14% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X-like 1, orphan receptor |
FLEROXACIN |
Purinergic P2X |
-14% |
NoneNone |
NoneNone |
View
|
epidermal growth factor receptor |
FLEROXACIN |
Protein Tyrosine Kinase, EGF Receptor |
-14% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
CITALOPRAM |
Cyclooxygenase COX-1 |
-14% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
CITALOPRAM |
Cyclooxygenase COX-1 |
-14% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 1d (Non-specific probe) |
EUCALYPTOL |
Adrenergic alpha1D |
-14% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
CITALOPRAM |
Potassium Channel [KATP] |
-14% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
CITALOPRAM |
Potassium Channel [KATP] |
-14% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
CITALOPRAM |
Potassium Channel [KATP] |
-14% |
NoneNone |
NoneNone |
View
|
interleukin 1 receptor, type I |
FENOPROFEN |
Interleukin IL-1 alpha |
-14% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 5 |
FELODIPINE |
Glutamate, Kainate |
-14% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 4 |
FELODIPINE |
Glutamate, Kainate |
-14% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 3 |
FELODIPINE |
Glutamate, Kainate |
-14% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 2 |
FELODIPINE |
Glutamate, Kainate |
-14% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 1 |
FELODIPINE |
Glutamate, Kainate |
-14% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
FELODIPINE |
Protein Serine/Threonine Kinase, ERK2 |
-14% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
FELODIPINE |
Protein Serine/Threonine Kinase, ERK2 |
-14% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
BROMISOVALUM |
GABAA, Benzodiazepine, Central |
-14% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
BROMISOVALUM |
GABAA, Benzodiazepine, Central |
-14% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, pi |
BROMISOVALUM |
GABAA, Benzodiazepine, Central |
-14% |
NoneNone |
NoneNone |
View
|
AT hook, DNA binding motif, containing 1 (DBSS) |
BROMISOVALUM |
GABAA, Benzodiazepine, Central |
-14% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, theta |
BROMISOVALUM |
GABAA, Benzodiazepine, Central |
-14% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
BROMISOVALUM |
GABAA, Benzodiazepine, Central |
-14% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
BROMISOVALUM |
GABAA, Benzodiazepine, Central |
-14% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
BROMISOVALUM |
GABAA, Benzodiazepine, Central |
-14% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
BROMISOVALUM |
GABAA, Benzodiazepine, Central |
-14% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
BROMISOVALUM |
GABAA, Benzodiazepine, Central |
-14% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
TOLPERISONE |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
TOLPERISONE |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
TOLPERISONE |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
TOLPERISONE |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
TOLPERISONE |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
TOLPERISONE |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
ZOLPIDEM |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
ZOLPIDEM |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, pi |
ZOLPIDEM |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
AT hook, DNA binding motif, containing 1 (DBSS) |
ZOLPIDEM |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, theta |
ZOLPIDEM |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
ZOLPIDEM |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
ZOLPIDEM |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
ZOLPIDEM |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
ZOLPIDEM |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
ZOLPIDEM |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
ZOLPIDEM |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
ZOLPIDEM |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
ZOLPIDEM |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
ZOLPIDEM |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
CITRIC ACID |
Dopamine Transporter |
-13% |
NoneNone |
NoneNone |
View
|
dopamine receptor 2 |
HYDROXYCHLOROQUINE |
Dopamine D2L |
-13% |
NoneNone |
NoneNone |
View
|
dopamine receptor 2 |
PHENACEMIDE |
Dopamine D2L |
-13% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
ANIRACETAM |
Cyclooxygenase COX-1 |
-13% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
ANIRACETAM |
Cyclooxygenase COX-1 |
-13% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
CHOLINE ALFOSCERATE |
Cyclooxygenase COX-1 |
-13% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
CHOLINE ALFOSCERATE |
Cyclooxygenase COX-1 |
-13% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
ALFACALCIDOL |
Cyclooxygenase COX-2 |
-13% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
ALFACALCIDOL |
Cyclooxygenase COX-2 |
-13% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
ERGOCALCIFEROL |
Cyclooxygenase COX-1 |
-13% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
ERGOCALCIFEROL |
Cyclooxygenase COX-1 |
-13% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
TRIMETAZIDINE |
Cyclooxygenase COX-1 |
-13% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
TRIMETAZIDINE |
Cyclooxygenase COX-1 |
-13% |
NoneNone |
NoneNone |
View
|
cholecystokinin A receptor |
1,3-DIPHENYLGUANIDINE |
Cholecystokinin CCKA |
-13% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
CHROMIUM(III) CHLORIDE |
Cyclooxygenase COX-1 |
-13% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
CHROMIUM(III) CHLORIDE |
Cyclooxygenase COX-1 |
-13% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
EPINEPHRINE |
Cyclooxygenase COX-1 |
-13% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
EPINEPHRINE |
Cyclooxygenase COX-1 |
-13% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 2 |
METHSCOPOLAMINE BROMIDE |
Chemokine CCR2B |
-13% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 4 |
DIMENHYDRINATE |
Chemokine CCR4 |
-13% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 4 |
METHAPYRILENE |
Chemokine CCR4 |
-13% |
NoneNone |
NoneNone |
View
|
cannabinoid receptor 1 (brain) |
1,3-DIPHENYLGUANIDINE |
Cannabinoid CB1 |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
DILTIAZEM |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
DILTIAZEM |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
DILTIAZEM |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
DILTIAZEM |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
DILTIAZEM |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4D |
CLOXACILLIN |
Phosphodiesterase PDE4 |
-13% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4B, cAMP specific |
CLOXACILLIN |
Phosphodiesterase PDE4 |
-13% |
NoneNone |
NoneNone |
View
|
protein kinase C, iota |
CINNARIZINE |
Phorbol Ester |
-13% |
NoneNone |
NoneNone |
View
|
protein kinase C, beta 1 |
CINNARIZINE |
Phorbol Ester |
-13% |
NoneNone |
NoneNone |
View
|
protein kinase C, delta |
CINNARIZINE |
Phorbol Ester |
-13% |
NoneNone |
NoneNone |
View
|
protein kinase C, mu |
CINNARIZINE |
Phorbol Ester |
-13% |
NoneNone |
NoneNone |
View
|
protein kinase C, theta |
CINNARIZINE |
Phorbol Ester |
-13% |
NoneNone |
NoneNone |
View
|
protein kinase C, iota |
CINNARIZINE |
Phorbol Ester |
-13% |
NoneNone |
NoneNone |
View
|
protein kinase C, epsilon |
CINNARIZINE |
Phorbol Ester |
-13% |
NoneNone |
NoneNone |
View
|
protein kinase C, zeta |
CINNARIZINE |
Phorbol Ester |
-13% |
NoneNone |
NoneNone |
View
|
protein kinase C, gamma |
CINNARIZINE |
Phorbol Ester |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
GADOPENTETATE DIMEGLUMINE |
Calcium Channel Type L, Benzothiazepine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
GADOPENTETATE DIMEGLUMINE |
Calcium Channel Type L, Benzothiazepine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
GADOPENTETATE DIMEGLUMINE |
Calcium Channel Type L, Benzothiazepine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
GADOPENTETATE DIMEGLUMINE |
Calcium Channel Type L, Benzothiazepine |
-14% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
STANOZOLOL |
Serotonin 5-HT1A |
-14% |
NoneNone |
NoneNone |
View
|
tachykinin receptor 1 |
CANTHARIDIN |
Tachykinin NK1 |
-14% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 5 |
STAVUDINE |
Glutamate, Kainate |
-14% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 4 |
STAVUDINE |
Glutamate, Kainate |
-14% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 3 |
STAVUDINE |
Glutamate, Kainate |
-14% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 2 |
STAVUDINE |
Glutamate, Kainate |
-14% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 1 |
STAVUDINE |
Glutamate, Kainate |
-14% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
RABEPRAZOLE |
Cyclooxygenase COX-2 |
-14% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
RABEPRAZOLE |
Cyclooxygenase COX-2 |
-14% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
PODOPHYLLOTOXIN |
Serotonin 5-HT2B |
-14% |
NoneNone |
NoneNone |
View
|
lymphocyte protein tyrosine kinase (mapped) |
CHLORAMBUCIL |
Protein Tyrosine Kinase, Lck |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
PENICILLIC ACID |
Calcium Channel Type L, Phenylalkylamine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
PENICILLIC ACID |
Calcium Channel Type L, Phenylalkylamine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
PENICILLIC ACID |
Calcium Channel Type L, Phenylalkylamine |
-14% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
PENICILLIC ACID |
Calcium Channel Type L, Phenylalkylamine |
-14% |
NoneNone |
NoneNone |
View
|